R33M (p.Arg33Met) variant of MS4A1 (B-lymphocyte antigen CD20)

R33M (p.Arg33Met) in MS4A1 (B-lymphocyte antigen CD20) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.15 / 1. The record also includes population frequency data and structural context.

R33M (p.Arg33Met) variant details